Aboveallislove
Super Moderator
Just announced: Vertex is entering into a collaboration agreement with Parion Sciences to test in Phase 2a Orcambi + P-1037 (the later of which Parion is already testing for all genotypes) for ddf508 with hope it will also hope df508. In vitro shows the two together have improved benefit. here's the press release with more details.
http://investors.vrtx.com/releasedetail.cfm?ReleaseID=916591
http://investors.vrtx.com/releasedetail.cfm?ReleaseID=916591